Dobe M Tablet 500 mg (Dopesilic Acid Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500~1000mg daily 2. Venous disease: Administer 750mg daily for 1~3 weeks, then administer 500mg daily. Administer after meals with plenty of fluid. Adjust the dose as appropriate according to age and symptoms.

This medication contains Dopesilic Acid Calcium Hydrate as its active ingredient and should not be used in certain patients. For example, individuals who are allergic to this medication or its ingredients, women who are pregnant or breastfeeding, and those with genetic disorders that prevent lactose digestion should not take this medication. Patients with impaired kidney function should use caution. This medication is primarily excreted via urine, so individuals with reduced kidney function may need to adjust the dose. In particular, patients with severe renal failure requiring dialysis may need dosage reduction. Patients with impaired liver function should also take caution when using this medication. The safety and efficacy of this medication have not been sufficiently studied in individuals with liver dysfunction, and treatment should be reconsidered if liver enzyme levels are elevated. Additionally, this medication contains sulfite ingredients, which can cause serious allergic reactions in patients with sulfite allergies or asthma. Rarely, serious side effects such as agranulocytosis, which involves a reduction in blood cell counts, may occur while taking this medication. In such cases, symptoms of infection such as high fever, stomatitis, and sore throat may develop, and patients should notify their doctor immediately if symptoms occur and confirm their condition through blood tests. Furthermore, allergic reactions such as skin rashes, hives, and facial swelling, as well as severe allergic reactions such as anaphylaxis, may occur, and if these symptoms appear, the medication should be discontinued immediately. Common side effects may include headache, abdominal pain, nausea, diarrhea, vomiting, joint pain, muscle pain, and liver function abnormalities, and patients should consult a physician if these symptoms are severe. Interactions with other medications are not known; however, this medication may affect the measurement of creatinine levels during blood tests, so it should be reported before testing. Finally, before taking this medication for the first time, necessary tests such as blood tests should be performed to ensure safe use.

• Agranulocytosis
• Neutropenia
• Leukopenia
• Skin rash
• Allergic dermatitis
• Itching
• Urticaria
• Facial swelling
• Anaphylactic reaction
• Headache

This medication should be stored in a tightly sealed container that blocks light, at a temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy and prevent degradation.

Appearance

White rectangular tablet

Package unit

10 tablets/bottle, 30 tablets/bottle, 90 tablets/bottle, 300 tablets/bottle